JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M104446200 on September 12, 2001

J. Biol. Chem., Vol. 276, Issue 46, 43221-43230, November 16, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/46/43221    most recent
M104446200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, X.
Right arrow Articles by Bates, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, X.
Right arrow Articles by Bates, P. J.

Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides*

Xiaohua XuDagger , Fofi HamhouyiaDagger , Shelia D. ThomasDagger , Tom J. Burke§, Allicia C. Girvan, W. Glenn McGregorDagger §, John O. TrentDagger ||, Donald M. MillerDagger , and Paula J. BatesDagger **

From the Human Molecular Biology Group, James Graham Brown Cancer Center, Departments of Dagger  Medicine, § Pharmacology/Toxicology,  Biochemistry/Molecular Biology, and || Chemistry, University of Louisville, Louisville, Kentucky 40202

The discovery of G-rich oligonucleotides (GROs) that have non-antisense antiproliferative activity against a number of cancer cell lines has been recently described. This biological activity of GROs was found to be associated with their ability to form stable G-quartet-containing structures and their binding to a specific cellular protein, most likely nucleolin (Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O., and Miller, D. M. (1999) J. Biol. Chem. 274, 26369-26377). In this report, we further investigate the novel mechanism of GRO activity by examining their effects on cell cycle progression and on nucleic acid and protein biosynthesis. Cell cycle analysis of several tumor cell lines showed that cells accumulate in S phase in response to treatment with an active GRO. Analysis of 5-bromodeoxyuridine incorporation by these cells indicated the absence of de novo DNA synthesis, suggesting an arrest of the cell cycle predominantly in S phase. At the same time point, RNA and protein synthesis were found to be ongoing, indicating that arrest of DNA replication is a primary event in GRO-mediated inhibition of proliferation. This specific blockade of DNA replication eventually resulted in altered cell morphology and induction of apoptosis. To characterize further GRO-mediated inhibition of DNA replication, we used an in vitro assay based on replication of SV40 DNA. GROs were found to be capable of inhibiting DNA replication in the in vitro assay, and this activity was correlated to their antiproliferative effects. Furthermore, the effect of GROs on DNA replication in this assay was related to their inhibition of SV40 large T antigen helicase activity. The data presented suggest that the antiproliferative activity of GROs is a direct result of their inhibition of DNA replication, which may result from modulation of a replicative helicase activity.


* This work was supported by the Department of Defense Prostate Cancer Initiative, the National Institutes of Health, and the Commonwealth of Kentucky Research Challenge Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: 204B Baxter Bldg., 570 S. Preston St., Louisville, KY 40202. Tel: 502-852-2432; Fax: 502-852-2356; E-mail: paula.bates@louisville.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Soundararajan, W. Chen, E. K. Spicer, N. Courtenay-Luck, and D. J. Fernandes
The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2358 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Teng, A. C. Girvan, L. K. Casson, W. M. Pierce Jr., M. Qian, S. D. Thomas, and P. J. Bates
AS1411 Alters the Localization of a Complex Containing Protein Arginine Methyltransferase 5 and Nucleolin
Cancer Res., November 1, 2007; 67(21): 10491 - 10500.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Qi, C.-P. Lin, X. Fu, L. M. Wood, A. A. Liu, Y.-C. Tsai, Y. Chen, C. M. Barbieri, D. S. Pilch, and L. F. Liu
G-Quadruplexes Induce Apoptosis in Tumor Cells
Cancer Res., December 15, 2006; 66(24): 11808 - 11816.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. R. Ireson and L. R. Kelland
Discovery and development of anticancer aptamers
Mol. Cancer Ther., December 1, 2006; 5(12): 2957 - 2962.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Benimetskaya, K. Ayyanar, N. Kornblum, D. Castanotto, J. Rossi, S. Wu, J. Lai, B. D. Brown, N. Popova, P. Miller, et al.
Bcl-2 Protein in 518A2 Melanoma Cells In vivo and In vitro.
Clin. Cancer Res., August 15, 2006; 12(16): 4940 - 4948.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. C. Girvan, Y. Teng, L. K. Casson, S. D. Thomas, S. Juliger, M. W. Ball, J. B. Klein, W. M. Pierce Jr., S. S. Barve, and P. J. Bates
AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin.
Mol. Cancer Ther., July 1, 2006; 5(7): 1790 - 1799.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Abdelrahim, C. H. Baker, J. L. Abbruzzese, and S. Safe
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
J Natl Cancer Inst, June 21, 2006; 98(12): 855 - 868.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Jiang, X.-S. Xu, and J. E. Russell
A Nucleolin-Binding 3' Untranslated Region Element Stabilizes {beta}-Globin mRNA In Vivo.
Mol. Cell. Biol., March 1, 2006; 26(6): 2419 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.
Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy
G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis
Cancer Res., September 15, 2004; 64(18): 6603 - 6609.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. H. Yoo, E. Bochkareva, A. Bochkarev, T.-C. Mou, and D. M. Gray
2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro
Nucleic Acids Res., April 2, 2004; 32(6): 2008 - 2016.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. R. Leliveld, R. T. Dame, M. A. Mommaas, H. K. Koerten, C. Wyman, A. A. A. M. Danen-van Oorschot, J. L. Rohn, M. H. M. Noteborn, and J. P. Abrahams
Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA
Nucleic Acids Res., August 15, 2003; 31(16): 4805 - 4813.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. Dapic, V. Abdomerovic, R. Marrington, J. Peberdy, A. Rodger, J. O. Trent, and P. J. Bates
Biophysical and biological properties of quadruplex oligodeoxyribonucleotides
Nucleic Acids Res., April 15, 2003; 31(8): 2097 - 2107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Mi, S. D. Thomas, X. Xu, L. K. Casson, D. M. Miller, and P. J. Bates
Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin
J. Biol. Chem., February 28, 2003; 278(10): 8572 - 8579.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.